Breaking News

CMC Biologics, IDT Biologika Expand Partnership

Add Cerbios-Pharma and Oncotec Pharma to strategic PROVEO ADC collaboration

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CMC Biologics a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, and IDT Biologika have added Cerbios-Pharma and Oncotec Pharma Produktion to PROVEO, their strategic collaboration for providing a complete and efficient solution to the market for the process development and manufacture of antibody drug conjugates (ADCs). Within the PROVEO collaborative partnership, CMC Biologics provides monoclonal antibody production, Cerbios perf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters